Blog For a Cure

“So, I haven’t done anything yet, but I think that when I go home after chemo this weekend, I am going to shave my head. I don’t know yet exactly how, though, because I know that if my mom helps, she will start to cry (and make me start to cry). As I do not have any sisters and really don’t know what my brothers would say, I think that I am going to ask my brother’s fiancee to help me. She is the closest thing I have to a sister, and I think she is the kind of person to handle it well. My mom and brothers have asked me why I want to shave it, and I can’t give a concrete answer other than the fact that it seems right, as if it’s the next step and something I need to do, regardless of how scary it seems.” Annie, a 18 year old college freshman with lymphoma.


The old adage says, “Pain shared is pained lessoned.” Nowhere is that more true than among cancer survivors. If you want to read about how others are feeling, dreaming, planning, celebrating, mourning and more, then you need to see “Blog for a Cure - A community of cancer survivors supporting each other.” From advice on head shaving to treatment protocols, there are hundreds of blogs on this site from men and women from all walks of life in all types of circumstances – surely some will reasonate with you.


For more information, visit http://www.blogforacure.com.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap